{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:02:48Z","timestamp":1767862968218,"version":"3.49.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,15]]},"DOI":"10.1093\/infdis\/jix337","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T03:11:32Z","timestamp":1500088292000},"page":"632-640","source":"Crossref","is-referenced-by-count":13,"title":["Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence"],"prefix":"10.1093","volume":"216","author":[{"given":"Neesha","family":"Rockwood","sequence":"first","affiliation":[{"name":"Department of Medicine, Imperial College, and"},{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Sirgel","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Streicher","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Warren","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Imperial College, and"},{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Imperial College, and"},{"name":"Francis Crick Institute, London,United Kingdom; and"},{"name":"Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"key\n\t\t\t\t20180216113024_CIT0001","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180216113024_CIT0002","doi-asserted-by":"crossref","first-page":"e0139017","DOI":"10.1371\/journal.pone.0139017","article-title":"Risk factors for acquired rifamycin and isoniazid resistance: a systematic review and meta-analysis","volume":"10","author":"Rockwood","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180216113024_CIT0003","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/cid\/ciu674","article-title":"Acquired rifampicin resistance in thrice-weekly antituberculosis therapy: impact of HIV and antiretroviral therapy","volume":"59","author":"Narendran","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180216113024_CIT0004","author":"Department of Health South Africa"},{"key":"key\n\t\t\t\t20180216113024_CIT0005","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1378\/chest.98.2.314","article-title":"Testing for isoniazid. An evaluation of the Arkansas method","volume":"98","author":"Schraufnagel","year":"1990","journal-title":"Chest"},{"key":"key\n\t\t\t\t20180216113024_CIT0006","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/jcm.35.4.907-914.1997","article-title":"Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology","volume":"35","author":"Kamerbeek","year":"1997","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180216113024_CIT0007","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/ncomms5812","article-title":"A robust SNP barcode for typing Mycobacterium tuberculosis complex strains","volume":"5","author":"Coll","year":"2014","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t20180216113024_CIT0008","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180216113024_CIT0009","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/JCM.02501-08","article-title":"Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation","volume":"47","author":"Springer","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180216113024_CIT0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/AAC.01209-13","article-title":"Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs","volume":"58","author":"Lee","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180216113024_CIT0011","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.meegid.2011.07.019","article-title":"Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa","volume":"12","author":"Streicher","year":"2012","journal-title":"Infect Genet Evol"},{"key":"key\n\t\t\t\t20180216113024_CIT0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","article-title":"Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis","volume":"17","author":"Gegia","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180216113024_CIT0013","doi-asserted-by":"crossref","first-page":"e86316","DOI":"10.1371\/journal.pone.0086316","article-title":"Clinical characteristics and treatment outcomes of patients with low- and high-concentration isoniazid-monoresistant tuberculosis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180216113024_CIT0014","doi-asserted-by":"crossref","first-page":"812","DOI":"10.5588\/ijtld.11.0637","article-title":"Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007\u20132009","volume":"16","author":"Gegia","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180216113024_CIT0015","doi-asserted-by":"crossref","first-page":"e1000150","DOI":"10.1371\/journal.pmed.1000150","article-title":"Standardized treatment of active tuberculosis in patients with previous treatment and\/or with mono-resistance to isoniazid: a systematic review and meta-analysis","volume":"6","author":"Menzies","year":"2009","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180216113024_CIT0016","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1001\/jama.283.19.2537","article-title":"Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries","volume":"283","author":"Espinal","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180216113024_CIT0017","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/thoraxjnl-2015-208262","article-title":"What are the most efficacious treatment regimens for isoniazid-resistant tuberculosis? A systematic review and network meta-analysis","volume":"71","author":"Stagg","year":"2016","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20180216113024_CIT0018","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2741\/1289","article-title":"Mechanisms of drug resistance in Mycobacterium tuberculosis","volume":"9","author":"Wade","year":"2004","journal-title":"Front Biosci"},{"key":"key\n\t\t\t\t20180216113024_CIT0019","doi-asserted-by":"crossref","first-page":"e83006","DOI":"10.1371\/journal.pone.0083006","article-title":"Association between Mycobacterium tuberculosis complex phylogenetic lineage and acquired drug resistance","volume":"8","author":"Yuen","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180216113024_CIT0020","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0140-6736(96)03027-9","article-title":"The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA","volume":"348","author":"Bradford","year":"1996","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180216113024_CIT0021","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1164\/rccm.200503-417OC","article-title":"Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis","volume":"173","author":"Burman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180216113024_CIT0022","doi-asserted-by":"crossref","DOI":"10.4102\/sajhivmed.v14i3.67","article-title":"Combined antiretroviral and anti-tuberculosis drug resistance following incarceration","volume":"14","author":"Stott","year":"2013","journal-title":"South Afr J HIV Med"},{"key":"key\n\t\t\t\t20180216113024_CIT0023","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/cid\/cix158","article-title":"Concentration-dependent antagonism and culture conversion in pulmonary tuberculosis","volume":"64","author":"Rockwood","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180216113024_CIT0024","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/jac\/dkp262","article-title":"Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis","volume":"64","author":"Sch\u00f6n","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180216113024_CIT0025","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1164\/ajrccm\/138.4.999","article-title":"Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan","volume":"138","author":"Suo","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"key\n\t\t\t\t20180216113024_CIT0026","doi-asserted-by":"crossref","first-page":"e70178","DOI":"10.1371\/journal.pone.0070178","article-title":"Population structure of mixed Mycobacterium tuberculosis infection is strain genotype and culture medium dependent","volume":"8","author":"Hanekom","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180216113024_CIT0027","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrmicro3076","article-title":"A problem of persistence: still more questions than answers?","volume":"11","author":"Balaban","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20180216113024_CIT0028","first-page":"10","article-title":"How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis","volume":"2","author":"Mitchison","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180216113024_CIT0029","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1128\/JCM.02499-08","article-title":"Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis","volume":"47","author":"Huang","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180216113024_CIT0030","doi-asserted-by":"crossref","first-page":"e108911","DOI":"10.1371\/journal.pone.0108911","article-title":"Re-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960","volume":"9","author":"Christianson","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180216113024_CIT0031","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/JCM.02378-13","article-title":"Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory","volume":"52","author":"Banu","year":"2014","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180216113024_CIT0032","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/JCM.01209-09","article-title":"Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results","volume":"47","author":"Van Deun","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180216113024_CIT0033","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JCM.00553-13","article-title":"Rifampin drug resistance tests for tuberculosis: challenging the gold standard","volume":"51","author":"Van Deun","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180216113024_CIT0034","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1469-0691.2011.03551.x","article-title":"The ins and outs of Mycobacterium tuberculosis drug susceptibility testing","volume":"17","author":"B\u00f6ttger","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180216113024_CIT0035","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1128\/JCM.00486-15","article-title":"Rapid whole-genome sequencing of Mycobacterium tuberculosis isolates directly from clinical samples","volume":"53","author":"Brown","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180216113024_CIT0036","doi-asserted-by":"crossref","first-page":"e7407","DOI":"10.1371\/journal.pone.0007407","article-title":"Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints","volume":"4","author":"Niemann","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180216113024_CIT0037","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S2213-2600(13)70231-5","article-title":"Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study","volume":"1","author":"Bryant","year":"2013","journal-title":"Lancet Respir Med"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/6\/632\/23990210\/jix337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:57:22Z","timestamp":1659229042000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/216\/6\/632\/3980289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,7,20]]},"published-print":{"date-parts":[[2017,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix337","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9,15]]},"published":{"date-parts":[[2017,7,20]]}}}